داروسازی اکسیر
دلر | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
-
Last Price: - 0.00
Close Price: -
Balance Sheet
AGM
Interim
2026/06/28 Fiscal Year 2026/03/2012 Month | 2025/05/31 Fiscal Year 2025/03/2012 Month | 2024/05/29 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Cash & Bank Balances | 968.923 Billion | 1.06 Trillion | 2.174 Trillion | |
Short-Term Investments | 3.289 Billion | 37.781 Billion | - | |
Trade Receivables | 41.202 Trillion | 33.986 Trillion | 23.143 Trillion | |
Prepayments | 3.033 Trillion | 3.381 Trillion | 5.541 Trillion | |
Raw Materials & Packaging Inventory | 9.209 Trillion | 8.54 Trillion | 7.496 Trillion | |
Work-in-Progress Inventory | 1.335 Trillion | 1.404 Trillion | 690.064 Billion | |
Finished Goods Inventory | 341.775 Billion | 594.158 Billion | 1.329 Trillion | |
Spare Parts Inventory | 744.31 Billion | 436.49 Billion | 443.696 Billion | |
Goods in Transit | 821.094 Billion | 1.283 Trillion | 767.271 Billion | |
Our Goods on Consignment with Others | 76.535 Billion | 33.049 Billion | 30.554 Billion | |
Other Inventories | 105.617 Billion | 34.592 Billion | - | |
Inventories | 12.594 Trillion | 12.286 Trillion | 10.75 Trillion | |
Total Current Assets | 57.802 Trillion | 50.751 Trillion | 41.608 Trillion | |
Long-Term Investments | 109.597 Billion | 93.835 Billion | 93.778 Billion | |
Long-Term Trade Receivables | 38.982 Billion | 23.581 Billion | 22.77 Billion | |
Intangible Assets | 2.06 Billion | 3.595 Billion | 2.088 Billion | |
Other Assets | 651 Million | 651 Million | 651 Million | |
Property, Plant & Equipment | 8.171 Trillion | 6.706 Trillion | 2.617 Trillion | |
Net Fixed Assets | 8.171 Trillion | 6.706 Trillion | 2.617 Trillion | |
Total Non-Current Assets | 8.323 Trillion | 6.827 Trillion | 2.737 Trillion | |
Total Assets | 66.124 Trillion | 57.579 Trillion | 44.344 Trillion | |
Trade Payables | 6.554 Trillion | 6.425 Trillion | 3.468 Trillion | |
Advances Received | 271.791 Billion | 55.533 Billion | 105.766 Billion | |
Income Tax Provision | 5.166 Trillion | 3.125 Trillion | 2.215 Trillion | |
Proposed & Payable Dividends | 7.702 Trillion | 9.331 Trillion | 5.698 Trillion | |
Current Borrowings | 16.013 Trillion | 18.158 Trillion | 19.204 Trillion | |
Total Current Liabilities | 35.706 Trillion | 37.094 Trillion | 30.69 Trillion | |
Employee Termination Benefits Provision | 862.363 Billion | 535.819 Billion | 340.992 Billion | |
Total Non-Current Liabilities | 862.363 Billion | 535.819 Billion | 340.992 Billion | |
Total Liabilities | 36.569 Trillion | 37.63 Trillion | 31.031 Trillion | |
Capital | 9.217 Trillion | 2.25 Trillion | 2.25 Trillion | |
Capital Raise in Progress | 2.15 Trillion | - | - | |
Retained Earnings | 17.358 Trillion | 14.137 Trillion | 10.861 Trillion | |
Legal Reserve | 921.7 Billion | 225 Billion | 225 Billion | |
Share Premium Reserve | -91.54 Billion | -30.946 Billion | -22.805 Billion | |
Total Equity | 29.556 Trillion | 19.948 Trillion | 13.313 Trillion | |
Total Liabilities & Equity | 66.124 Trillion | 57.579 Trillion | 44.344 Trillion | |
Approved Capital | 9.217 Trillion | 2.25 Trillion | 2.25 Trillion | |
Approved Capital Raise in Progress | 2.15 Trillion | - | - | |
Approved Retained Earnings | 8.694 Trillion | 6.138 Trillion | 3.841 Trillion | |
Approved Legal Reserve | 921.7 Billion | 225 Billion | 225 Billion | |
Total Approved Equity (at AGM) | 20.983 Trillion | 8.613 Trillion | 6.316 Trillion | |
کالای امانی دیگران نزد ما | 39.05 Billion | 38.114 Billion | 7.047 Billion | |
Revaluation Surplus of Property, Plant and Equipment | 330 Million | 3.367 Trillion | - |